Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Mar 24.
Published in final edited form as: Biochemistry. 2009 Mar 24;48(11):2304–2306. doi: 10.1021/bi900114z

α-Synuclein binds large unilamellar vesicles as an extended helix

Adam J Trexler 1, Elizabeth Rhoades 1,*
PMCID: PMC2837115  NIHMSID: NIHMS168599  PMID: 19220042

Abstract

Interactions between the synaptic protein α-Synuclein and cellular membranes may be relevant both to its native function as well as its role in Parkinson’s disease. We use single molecule Förster resonance energy transfer to probe the structure of α-Synuclein bound to detergent micelles and lipid vesicles. We find evidence that it forms a bent-helix when bound to highly curved detergent micelles, whereas it binds more physiological 100 nm diameter lipid vesicles as an elongated helix. Our results highlight the influence of membrane curvature in determining α-Synuclein conformation, which may be important for both its normal and disease-associated functions.


α-Synuclein (AS) is the primary protein constituent of cytoplasmic Lewy bodies and Lewy neurites that are the pathological hallmark of Parkinson’s Disease (PD)(1, 2). Although it is strongly implicated in disease progression (3) the precise role of AS in PD is unclear. The native function of AS is also poorly understood, although evidence suggests that it may play a role both in maintaining neuronal plasticity and in the regulation of synaptic vesicle recycling(4, 5).

AS is disordered in solution(6) but undergoes a conformational change to an α-helical structure upon association with negatively charged membranes(7, 8). A number of in vitro studies have characterized the interactions of AS both with detergent micelles and lipid membranes (reviewed in (9)). However, there is conflicting evidence as to whether AS demonstrates preferential affinities for specific phospholipids(712) as well as if association with lipids inhibits or promotes AS aggregation or oligomerization(1216). A further matter of debate is the configuration of micelle or vesicle bound AS, with contrasting models proposing either an extended, continuous helix(1720) or two anti-parallel, non-interacting helices(2124), with an unstructured loop region between residues ~40–45 (Figure 1). Characterizing these conformations is of great interest, as membrane-bound structures may be pertinent both to native and disease-associated functions.

Figure 1.

Figure 1

Possible configurations of membrane-bound AS. Bottom, bent-helix model, from NMR structure of AS on SDS micelles (PDB: 1XQ8). Top, elongated helix model (cartoon from PyMol). Mutations for labeling are shown as blue spheres. Arrows on both molecules are color-matched to show the expected relative distances compared with the three AS FRET constructs described in the text: AS-S9C-T72C (red), AS-T33C-T72C (yellow), AS-S9C-T33C (blue). All mutations are in the helix-forming region (residues 1–90) and FRET between these locations distinguishes between these possible structural models

Here we use single molecule Förster resonance energy transfer (FRET) to probe the helical structure of AS bound to SDS micelles and large unilamellar vesicles (LUVs). In FRET, the energy transfer efficiency (ETeff) is dependent upon the distance between donor and acceptor fluorophores to the sixth power (25). In single molecule studies of protein conformations, each protein is labeled with a donor and an acceptor fluorophore. Photon bursts from the labeled proteins are collected as they diffuse through a diffraction-limited excitation volume. ETeff is calculated as: ETeff= Ia°/(Ia°+γId°), where Ia° and Id° are the photon counts on the acceptor and donor channels, respectively, corrected for background and signal bleed-through; γ accounts for properties of the instrument and fluorophores as detailed in the SI(26). An ETeff is calculated for each burst and a histogram is compiled of the individual values.

Single and double cysteine mutants of wild-type AS were engineered to allow for site-specific labeling with maleimide fluorophores. Mutations were introduced at residues S9, T33, and T72 and AS-S9C-T72C, AS-T33C-T72C, and AS-S9C-T33C double mutants were used for FRET measurements (Figure 1).The protein was expressed and purified as described previously(27), then labeled with donor (Alexa 488 maleimide) and acceptor (Alexa 594 maleimide) fluorophores generally following the protocol provided by the manufacturer (Invitrogen: SI for details). It was confirmed by circular dichroism and fluorescence correlation spectroscopy that the presence of the fluorophores did not significantly perturb binding of AS to either SDS micelles or LUVs ((27) and SI for details). Steady state anisotropy measurements showed a low anisotropy value for both fluorophores at all mutation sites, indicating free rotation of the fluorophores with minimal artifacts in the ETeff calculations (SI for details). The expected Ro for these fluorophores is ~54 Å(28).

Measurements were made with ~90 pM AS in buffer (20mM Tris, 30mM NaCl, pH 7.4) or in the presence of sodium dodecyl sulfate (SDS) (40 mM) or ~100 nm diameter 1-palmitoyl-2-oleoyl-phosphatidylserine (POPS) LUVs (160 µM lipid). These conditions were chosen such that not only is all the protein expected to be bound, but that only a single protein is bound per micelle or vesicle. NMR studies have shown that 40 mM SDS is sufficient to fully bind 100 µM AS (29), and thus is in great excess for the 90 pM protein used in this study The partition coefficient of fluorescently labeled wild-type AS for 100% POPS LUVs has been measured as ~3µM (lipid concentration) under solution conditions similar to the ones we use (27). Based on this number, we expect >98% of the protein to be bound and we calculate the vesicle:protein ratio to be >20:1. POPS was chosen for the work discussed here both because AS binds to it with high affinity and because phosphatidylserine comprises up to 30% of the lipid content of cellular membranes. However, other studies indicate that lipid composition may influence the membrane-bound conformation of AS (13), and thus this topic is an area of ongoing investigation in our group.

The resulting ETeff histograms for AS-S9C-T72C are plotted in Figure 2. In buffer, the ETeff peak value is 0.64 and shifts to 0.86 in the presence of SDS micelles (Figure 2A). These ETeff values are roughly what was expected based on the bent-helix model, where residues 9 and 72 are brought into close proximity upon helix formation (Figure 1) and exhibit the same general trends as the ETeff values measured for SDS micelle bound AS in another recent study which used a different acceptor fluorophore(30). While there are difficulties associated with calculating distances from ETeff, due to uncertainties in contribution of the fluorophore linkers (31) both of our measured ETeff values are in good agreement with what is predicted for a random coil (in solution) and for the bent-helix (on SDS micelles) (21).

Figure 2.

Figure 2

ETeff histograms of AS-S9C-T72C in buffer (A) or in the presence of 40 mM SDS (B). Each histogram contains >2000 events. The high ETeff observed in the micelle bound form of AS indicates that residues 9 and 72 are brought into close proximity, as expected based on the model illustrated in Figure 1. The lack of measurable energy transfer for the vesicle bound protein (not shown) suggests that the protein takes a more extended conformation when bound to vesicles.

However, when bound to both 50 and 100 nm diameter LUVs (data not shown), the ETeff drops effectively to 0, indicating that the distance between the fluorophores is either too great to be measured or is a very low value (ETeff< 0.1), such that we are unable to distinguish it from the ETeff=0 peak that arises from mislabeled proteins (see SI for discussion). In a single, unbroken helix, the separation between residues 9 and 72 is expected to be between 9 and 10 nm, at the limit of the distance range that should be detectable by our donor-acceptor fluorophores (SI for details). These data provide further evidence that all of the protein is either micelle or vesicle bound during our measurements. If a significant fraction of AS remains free in the micelle or LUV experiments, the free subpopulations would be observed with ETeff =0.64 and we do not find any evidence of unbound protein in our histograms.

The AS-T33C-T72C construct was designed to further probe the structure of the vesicle bound protein (Figure 1). The ETeff of AS-T33C-T72C bound to SDS micelles (ETeff =0.81) was higher than that of the free protein (ETeff~ 0.72) indicating closer contact between the donor and acceptor fluorophores (Figure 3A & B). We are also able to observe a clear ETeff =0.57 peak for LUV bound AS-T33C-T72C (Figure 3C). This shift to smaller ETeff as compared to the micelle bound protein suggests that residues 33 and 72 are further separated when bound to LUVs, supporting our prediction that AS forms an elongated helix on LUVs.

Figure 3.

Figure 3

ETeff histograms of AS-T33C-T72C in buffer (A) or in the presence of 40 mM SDS (B) or 160 µM POPS (C). In contrast to AS-S9C-T72C, we are able to observe three distinct conformations in the three measurement conditions for this construct. Of primary importance is that this data distinguishes between the micelle bound (B) and vesicle bound (C) conformations of AS and supports that the vesicle bound protein is more extended (Figure 1).

As a control, the helical region probed by AS-S9C-T33C was expected to be independent of whether the overall conformation was bent or extended and the measured ETeff values for micelle and LUV samples were essentially indistinguishable (ETeff ~0.8; Figure S4).

This study establishes the viability of single molecule FRET for characterizing membrane-bound conformations of AS. There is a fair amount of discussion in the literature about the meaning of the width of single molecule ETeff histograms. Broadening is often attributed to dynamics that are slow on the timescale of diffusion (32). While AS is disordered in solution and thus expected to be highly dynamic, long-range contacts exist between the C-terminus and the central region of the protein (33) which may restrict motion and slow dynamics. For the AS constructs studied here, the ETeff distributions in buffer are wider than the micelle or LUV bound ones (σbuffer=0.27 and σmicelle=0.17 for AS-S9C-T72C and σbuffer=0.31, σmicelle=0.21, and σLUV=0.24 for AS-T33C-T72C). The helical micelle and LUV bound states are more restricted conformations, resulting in reduced dynamic motion and narrower ETeff histograms. However, we note that both the micelle and LUV bound distributions are still rather wide for the AS-T33C-T72C construct. This may be due to the probe at residue 33 which is close to the loop region of the bent helix; this region is thought to remain disordered (17) even while the overall conformation of the protein adopts an extended helix. The T33C probe may reflect increased dynamics of this region of both the micelle and the vesicle bound protein (34), either due to fraying of the helix or the mobility of adjacent residues. We also cannot eliminate the possibility that peak broadening results from AS sampling two or more specific conformations with close mean ETeff values that are not resolved in our measurements.

A number of recent studies highlight the ongoing debate regarding the physiologically relevant form, bent or extended membrane-bound helix, of AS. Our findings are in good agreement with two recent reports - an ESR study of AS bound to lipid vesicles and bicelles (19) and a combined EPR and molecular dynamics simulation study of AS bound to lipid vesicles (20) – both of which find that AS binds to these model membranes in an extended helix. While there is a strong argument to be made in favor of lipid bilayers as a much more physiologically relevant model system, a third study of SDS-induced folding of AS also concluded that at high detergent concentrations, where rod-like micelles are expected to dominate over highly-curved spherical ones, AS populates an alternative conformation, suggested to be the elongated helix(35). Ours, and these other recent findings, are in direct contrast to a second recent EPR study which found evidence for a bent-helix on ~20–30 nm diameter vesicles(23).

This study emphasizes the role of the physical parameters of the membrane mimetic, particularly curvature, in determining the conformation of membrane-bound AS. Membrane binding is closely associated with both AS native function and its pathology in PD. In PD, it is hypothesized that AS may bind and permeabilize the plasma membrane(36). On the scale of the helical region of AS, the plasma membrane is a low curvature surface and thus the mechanism of membrane disruption could involve the elongated helical form of AS. However, the native function of AS is thought to involve binding to much more highly curved synaptic vesicles. Thus both membrane-bound structures we observe may be important to understanding AS. It remains to be determined precisely how vesicle curvature mediates the conformational switch from bent to elongated helix and how these structures relate to the native function of AS and its role in PD

Supplementary Material

1_si_001

ACKNOWLEDGMENT

We thank David Eliezer for the wild-type AS plasmid, A. Miranker, E. Sevcsik, and E. Middleton for reading the manscript and A. Nath for help creating Figure 1.

Footnotes

This work was supported by a grant from the Ellison Medical Foundation..

SUPPORTING INFORMATION PARAGRAPH

Experimental details of protein expression and labeling; single molecule measurements and analysis; anisotropy and circular dichroism controls. This material is available free of charge via the internet at http://pubs.acs.org..

REFERENCES

  • 1.Goedert M. Nat. Rev. Neurosci. 2001;2:492–501. doi: 10.1038/35081564. [DOI] [PubMed] [Google Scholar]
  • 2.Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DAC, Kondo J, Ihara Y, Saitoh T. Proc. Natl. Acad. Sci. 1993;90:11282–11286. doi: 10.1073/pnas.90.23.11282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cookson MR. Annu. Rev. Biochem. 2005;74:29–52. doi: 10.1146/annurev.biochem.74.082803.133400. [DOI] [PubMed] [Google Scholar]
  • 4.George JM, Jin H, Woods WS, Clayton DF. Neuron. 1995;15:361–372. doi: 10.1016/0896-6273(95)90040-3. [DOI] [PubMed] [Google Scholar]
  • 5.Lotharius J, Brundin P. Hum. Mol. Genet. 2002;11:2395–2407. doi: 10.1093/hmg/11.20.2395. [DOI] [PubMed] [Google Scholar]
  • 6.Weinreb PH, Zhen WG, Poon AW, Conway KA, Lansbury PT. Biochemistry. 1996;35:13709–13715. doi: 10.1021/bi961799n. [DOI] [PubMed] [Google Scholar]
  • 7.Davidson WS, Jonas A, Clayton DF, George JM. J. Biol. Chem. 1998;273:9443–9449. doi: 10.1074/jbc.273.16.9443. [DOI] [PubMed] [Google Scholar]
  • 8.Jo EJ, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE. J. Biol. Chem. 2000;275:34328–34334. doi: 10.1074/jbc.M004345200. [DOI] [PubMed] [Google Scholar]
  • 9.Beyer K. Cell Biochem. Biophys. 2007;47:285–299. doi: 10.1007/s12013-007-0014-9. [DOI] [PubMed] [Google Scholar]
  • 10.Narayanan V, Scarlata S. Biochemistry. 2001;40:9927–9934. doi: 10.1021/bi002952n. [DOI] [PubMed] [Google Scholar]
  • 11.Perrin RJ, Woods WS, Clayton DF, George JM. J. Biol. Chem. 2000;275:34393–34398. doi: 10.1074/jbc.M004851200. [DOI] [PubMed] [Google Scholar]
  • 12.Zhu M, Li J, Fink AL. J. Biol. Chem. 2003;278:40186–40197. doi: 10.1074/jbc.M305326200. [DOI] [PubMed] [Google Scholar]
  • 13.Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet JC, Cramer WA. Biochemistry. 2007;46:14369–14379. doi: 10.1021/bi701275p. [DOI] [PubMed] [Google Scholar]
  • 14.Lee HJ, Choi C, Lee SJ. J. Biol. Chem. 2002;277:671–678. doi: 10.1074/jbc.M107045200. [DOI] [PubMed] [Google Scholar]
  • 15.Zhao HX, Tuominen EKJ, Kinnunen PKJ. Biochemistry. 2004;43:10302–10307. doi: 10.1021/bi049002c. [DOI] [PubMed] [Google Scholar]
  • 16.Zhu M, Fink AL. J. Biol. Chem. 2003;278:16873–16877. doi: 10.1074/jbc.M210136200. [DOI] [PubMed] [Google Scholar]
  • 17.Bussell R, Eliezer D. J. Mol. Biol. 2003;329:763–778. doi: 10.1016/s0022-2836(03)00520-5. [DOI] [PubMed] [Google Scholar]
  • 18.Jao CC, Der-Sarkissian A, Chen J, Langen R. Proc. Natl. Acad. Sci. U. S. A. 2004;101:8331–8336. doi: 10.1073/pnas.0400553101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Georgieva ER, Ramlall TF, Borbat PP, Freed JH, Eliezer D. J. Am. Chem. Soc. 2008;130:12856–12857. doi: 10.1021/ja804517m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jao CC, Hegde BG, Chen J, Haworth IS, Langen R. Proc. Natl. Acad. Sci. U.S.A. 2008;105:19666–19671. doi: 10.1073/pnas.0807826105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Borbat P, Ramlall TF, Freed JH, Eliezer D. J. Am. Chem. Soc. 2006;128:10004–10005. doi: 10.1021/ja063122l. [DOI] [PubMed] [Google Scholar]
  • 22.Chandra S, Chen XC, Rizo J, Jahn R, Sudhof TC. J. Biol. Chem. 2003;278:15313–15318. doi: 10.1074/jbc.M213128200. [DOI] [PubMed] [Google Scholar]
  • 23.Drescher M, Veldhuis G, van Rooijen BD, Milikisyants S, Subramaniam V, Huber M. J. Am. Chem. Soc. 2008;130:7796–7797. doi: 10.1021/ja801594s. [DOI] [PubMed] [Google Scholar]
  • 24.Ulmer TS, Bax A, Cole NB, Nussbaum RL. J. Biol. Chem. 2005;280:9595–9603. doi: 10.1074/jbc.M411805200. [DOI] [PubMed] [Google Scholar]
  • 25.Forster T. Ann. Phys.-Berlin. 1948;2:55–75. [Google Scholar]
  • 26.Ha TJ, Ting AY, Liang J, Deniz AA, Chemla DS, Schultz PG, Weiss S. Chem. Phys. 1999;247:107–118. [Google Scholar]
  • 27.Rhoades E, Ramlall TF, Webb WW, Eliezer D. Biophys. J. 2006;90:4692–4700. doi: 10.1529/biophysj.105.079251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schuler B, Lipman EA, Eaton WA. Nature. 2002;419:743–747. doi: 10.1038/nature01060. [DOI] [PubMed] [Google Scholar]
  • 29.Eliezer D, Kutluay E, Bussell R, Browne G. J. Mol. Biol. 2001;307:1061–1073. doi: 10.1006/jmbi.2001.4538. [DOI] [PubMed] [Google Scholar]
  • 30.Veldhuis G, Segers-Nolten I, Ferlemann E, Subramaniam V. ChemBioChem. 2008 doi: 10.1002/cbic.200800644. early view. [DOI] [PubMed] [Google Scholar]
  • 31.McCarney ER, Werner JH, Bernstein SL, Ruczinski I, Makarov DE, Goodwin PM, Plaxco KW. J. Mol. Biol. 2005;352:672–682. doi: 10.1016/j.jmb.2005.07.015. [DOI] [PubMed] [Google Scholar]
  • 32.Nir E, Michalet X, Hamadani KM, Laurence TA, Neuhauser D, Kovchegov Y, Weiss S. J. Phys. Chem. B. 2006;110:22103–22124. doi: 10.1021/jp063483n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM. J. Am. Chem. Soc. 2005;127:476–477. doi: 10.1021/ja044834j. [DOI] [PubMed] [Google Scholar]
  • 34.Bortolus M, Tombolato F, Tessari I, Bisaglia M, Mammi S, Bubacco L, Ferrarini A, Maniero AL. J. Am. Chem. Soc. 2008;130:6690–6691. doi: 10.1021/ja8010429. [DOI] [PubMed] [Google Scholar]
  • 35.Ferreon ACM, Deniz AA. Biochemistry. 2007;46:4499–4509. doi: 10.1021/bi602461y. [DOI] [PubMed] [Google Scholar]
  • 36.Volles MJ, Lansbury PT. Biochemistry. 2002;41:4595–4602. doi: 10.1021/bi0121353. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES